Your browser doesn't support javascript.
loading
Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.
Chen, Kexin; Yang, Da; Li, Xiangchun; Sun, Baocun; Song, Fengju; Cao, Wenfeng; Brat, Daniel J; Gao, Zhibo; Li, Haixin; Liang, Han; Zhao, Yanrui; Zheng, Hong; Li, Miao; Buckner, Jan; Patterson, Scott D; Ye, Xiang; Reinhard, Christoph; Bhathena, Anahita; Joshi, Deepa; Mischel, Paul S; Croce, Carlo M; Wang, Yi Michael; Raghavakaimal, Sreekumar; Li, Hui; Lu, Xin; Pan, Yang; Chang, Han; Ba, Sujuan; Luo, Longhai; Cavenee, Webster K; Zhang, Wei; Hao, Xishan.
Afiliación
  • Chen K; Department of Epidemiology and Biostatistics.
  • Yang D; Department of Pathology, University of Texas MD Anderson Cancer Center Informatics Center, Houston, TX 77030; Center of Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261;
  • Li X; Beijing Genomics Institute-Shenzhen, Shenzhen 518083, Guangdong, People's Republic of China; Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong 999077, People's Republic of China
  • Sun B; Department of Pathology, and.
  • Song F; Department of Epidemiology and Biostatistics.
  • Cao W; Department of Pathology, and.
  • Brat DJ; Department of Oncology Discovery, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322;
  • Gao Z; Beijing Genomics Institute-Shenzhen, Shenzhen 518083, Guangdong, People's Republic of China;
  • Li H; Department of Epidemiology and Biostatistics.
  • Liang H; Department of Gastrointestinal Surgery, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, People's Republic of China;
  • Zhao Y; Department of Epidemiology and Biostatistics.
  • Zheng H; Department of Epidemiology and Biostatistics.
  • Li M; Beijing Genomics Institute-Shenzhen, Shenzhen 518083, Guangdong, People's Republic of China;
  • Buckner J; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905;
  • Patterson SD; Medical Sciences, Amgen Inc., Thousand Oaks, CA 91320;
  • Ye X; Lilly China Research and Development Center and.
  • Reinhard C; Translational Sciences Oncology, Eli Lilly and Company, Indianapolis, IN 46285;
  • Bhathena A; Translational Oncology & Personalized Medicine, AbbVie Inc., North Chicago, IL 60064;
  • Joshi D; Exploratory Clinical & Translational Research, Bristol-Myers Squibb India, Mumbai 400013, India;
  • Mischel PS; Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA 92093;
  • Croce CM; Human Cancer Genetics Program, Ohio State University, Columbus, OH 43210;
  • Wang YM; The National Foundation for Cancer Research, Bethesda, MD 20814;
  • Raghavakaimal S; The National Foundation for Cancer Research, Bethesda, MD 20814;
  • Li H; Department of Epidemiology and Biostatistics, Department of Pathology, and Department of Gastrointestinal Surgery, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, Peopl
  • Lu X; Translational Oncology & Personalized Medicine, AbbVie Inc., North Chicago, IL 60064;
  • Pan Y; Medical Sciences, Amgen Inc., Thousand Oaks, CA 91320;
  • Chang H; Applied Genomics and Bioinformatics, Bristol-Myers Squibb, Princeton, NJ 08540;
  • Ba S; The National Foundation for Cancer Research, Bethesda, MD 20814; Asian Fund for Cancer Research, Hong Kong, People's Republic of China; and.
  • Luo L; Beijing Genomics Institute-Shenzhen, Shenzhen 518083, Guangdong, People's Republic of China; Department of Biology, University of Copenhagen, DK-1165 Copenhagen, Denmark.
  • Cavenee WK; Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA 92093; wcavenee@ucsd.edu xishanhao@sina.com wzhang@mdanderson.org.
  • Zhang W; Department of Pathology, University of Texas MD Anderson Cancer Center Informatics Center, Houston, TX 77030; wcavenee@ucsd.edu xishanhao@sina.com wzhang@mdanderson.org.
  • Hao X; Department of Epidemiology and Biostatistics, Department of Pathology, and Department of Gastrointestinal Surgery, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, Peopl
Proc Natl Acad Sci U S A ; 112(4): 1107-12, 2015 Jan 27.
Article en En | MEDLINE | ID: mdl-25583476
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma / Pueblo Asiatico / Mutación / Proteínas de Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma / Pueblo Asiatico / Mutación / Proteínas de Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2015 Tipo del documento: Article